- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.09. | Glenmark Pharma gets EIR for Goa facility from US FDA | 4 | capitalmarket.com | ||
| 22.09. | Glenmark Pharmaceuticals Ltd spurts 0.5%, gains for fifth straight session | 2 | capitalmarket.com | ||
| 21.09. | Pharma Stocks Rally: BSE Healthcare index hits new high, Sun Pharma, Torrent Pharma, Glenmark gain up to 5% | 4 | ZEE Business | ||
| 10.09. | Glenmark, South Piedmont Launch Pharma Training Facility | 4 | Contract Pharma | ||
| 26.08. | Glenmark Pharmaceuticals Ltd soars 1.8%, rises for third straight session | 2 | capitalmarket.com | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 21.08. | Glenmark Pharma's US arm launches Calcium Gluconate injection in various formats | 2 | capitalmarket.com | ||
| 21.08. | Glenmark Pharmaceuticals among 5 stocks showing bullish RSI upswing | 2 | Times of India | ||
| 20.08. | Glenmark Pharma gets USFDA nod for Fluticasone Propionate Nasal Spray | 4 | capitalmarket.com | ||
| 03.08. | Glenmark Q1 FY27 slides: 23% revenue growth, innovation pipeline expands | 3 | Investing.com | ||
| 15.07. | Glenmark Pharmaceuticals Ltd soars 0.08%, up for fifth straight session | 3 | capitalmarket.com | ||
| 06.07. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 2 | capitalmarket.com | ||
| 06.07. | Glenmark Pharma gains as US arm launches generic Olanzapine injection | 2 | capitalmarket.com | ||
| 17.06. | Glenmark Pharma arm launches generic Methylene Blue Injection in US market | 3 | capitalmarket.com | ||
| 11.06. | Glenmark Pharmaceuticals launches Winlevi across key European markets | 2 | capitalmarket.com | ||
| 11.06. | Cosmo Pharmaceuticals N.V.: Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark | 982 | Newsfile | Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) ("Cosmo") is pleased to make known that its commercial partner Glenmark Specialty S.A (GSSA), a wholly-owned... ► Artikel lesen | |
| 10.06. | Stock Alert: KRN Heat, Patanjali Foods, Bharti Airtel, Dixon Tech, Glenmark Pharma, Bharti Hexacom | 3 | capitalmarket.com | ||
| 05.06. | Glenmark Pharma launches generic Lacosamide injection in US | 2 | capitalmarket.com | ||
| 02.06. | Klage gegen Glenmark: Lieferengpässe: Kein Schadenersatz für DAK | 4 | APOTHEKE ADHOC | ||
| 01.06. | Stocks to Watch Today (June 01, 2026): IndiGo, Glenmark Pharma, IREDA, NMDC, Jubilant Pharmova, Cyient and more | 2 | ZEE Business | ||
| 01.06. | Stock Alert: RPP Infra Projects, Indigo, NMDC, GRM Overseas, Glenmark Pharma, NOCIL | 2 | capitalmarket.com |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 1,835 | +0,03 % | SINOPHARM (01099): ANNOUNCEMENT CONTINUING CONNECTED TRANSACTIONS: 2026 INFORMATION TECHNOLOGY SERVICES FRAMEWORK AGREEMENT | ||
| CSPC PHARMA | 0,929 | +1,49 % | CSPC PHARMA Initiates Phase I Clinical Trial in China for SYS6077 Injection for Treatment of Advanced Malignant Tumors | ||
| WUXI BIOLOGICS | 5,160 | -3,01 % | WuXi Biologics at Festival of Biologics Basel 2026: Turning Scientific Complexity into Commercial Certainty | WuXi Biologics at Festival of Biologics Basel 2026: Turning Scientific Complexity into Commercial Certainty
BASEL, Switzerland, Oct. 19, 2026 /PRNewswire/ -- More than 3,000 industry professionals... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,794 | -3,89 % | FOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK | ||
| GEDEON RICHTER | 36,120 | 0,00 % | Gedeon Richter Plc.: Transactions with Treasury Shares | ||
| DR REDDYS | 12,900 | +1,57 % | Dr. Reddy's Laboratories Profit Drops In Q2 | NEW DELHI (dpa-AFX) - Friday, Dr. Reddy's Laboratories Limited (RDY) announced its financial results for the second quarter of fiscal 2027.Profit for the period stood at INR 9,134 million, or... ► Artikel lesen | |
| ASPEN PHARMACARE | 8,500 | 0,00 % | ASPEN PHARMACARE HOLDINGS LIMITED - Availability of Integrated Reporting Suite, B-BBEE Verification Certificate and Further Notice of Annual General Meeting | ||
| SHANGHAI PHARMACEUTICALS | 1,280 | +3,23 % | Dividendenbekanntmachungen (23.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANCE AUTO PARTS INC US00751Y1064 0,25 USD EUR ALPHAMIN RESOURCES CORP MU0456S00006 0,13 CAD 0,0827 EUR AMERICAN FINANCIAL GROUP... ► Artikel lesen | |
| LUYE PHARMA | 0,179 | -1,65 % | LUYE PHARMA (02186): INTERIM REPORT 2026 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,081 | -2,99 % | Dividendenbekanntmachungen (30.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABACUS GROUP UTS AU0000291882 0,0212 AUD 0,0128 EUR ACADIA REALTY TRUST US0042391096 0,2 USD 0,175 EUR ACADIAN TIMBER CORP CA0042721005 0... ► Artikel lesen | |
| HANSOH PHARMACEUTICAL | 3,859 | +4,75 % | GSK's B7-H3 ADC drives 67% cancer risk reduction in Hansoh's phase 3 China trial | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,510 | +0,99 % | CHINARES PHARMA (03320): ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR BOYA BIO-PHARMACEUTICAL FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026 | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,805 | -1,23 % | Dividendenbekanntmachungen (15.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBOTT LABORATORIES US0028241000 0,63 USD 0,5648 EUR ABBOTT LABORATORIES CDR CA0028221046 0,1096 CAD 0,069 EUR ABBVIE INC US00287Y1091 1... ► Artikel lesen | |
| KALBE FARMA | 0,027 | -3,57 % | Dividendenbekanntmachungen (04.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-LIVING SMART CITY SERVICES CO LTD CNE100002RY5 0,0688 HKD 0,0075 EUR ADESSO SE DE000A0Z23Q5 - 0,78 EUR AGEAS SA/NV ADR US00844W2089 2... ► Artikel lesen | |
| BAYER | 47,960 | +4,19 % | Satte Kursgewinne mit der grünen Transformation! Wie Coca-Cola, Bayer, MustGrow und PepsiCo an die Zukunft denken | Erstellt und veröffentlicht im Auftrag von MustGrow Biologics Corp. Trotz regulatorischer Fortschritte bleibt die Welternährungslage extrem prekär. Laut einem aktuellen Bericht der Welthungerhilfe und... ► Artikel lesen |
GLENMARK PHARMACEUTICALS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.